Lilly’s CEO Calls for Reform of US Drug Safety System

Sidney Taurel, CEO, Eli Lilly and Company called on the health care industry, medical community and U.S. government to work on a health information technology system to provide rapid and useful insights on the effectiveness of medicines while improving drug safety.